CAVAC Swings to Net Loss in Third Quarter

PUBT · 1d ago
CAVAC Swings to Net Loss in Third Quarter
  • CAVAC posted a third-quarter 2026 net loss of 146 million won, versus a year-earlier profit of 1.7 billion won.
  • Operating profit rose 2.9% year over year to 1.59 billion won.
  • Revenue increased 4.8% from a year earlier to 11.51 billion won.
  • Sequentially, operating profit climbed 39.3%, while revenue fell 3.3%.
  • Nine-month operating profit increased 7.5% to 5.73 billion won.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CAVAC - Choong Ang Vaccine Laboratory Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261105900802), on November 05, 2026, and is solely responsible for the information contained therein.